Study of Physicochemical Properties and Development of Pharmaceutial Analysis of the New Antiarrhythmic Class III Drug Cardiocyclide

Author： Grushevskaya L. N.   Avdyunina N. I.   Stepanenko O. B.   Pyatin B. M.   Prokof'eva V. I.   Lezina V. P.  

Publisher： Springer Publishing Company

ISSN： 0091-150X

Source： Pharmaceutical Chemistry Journal, Vol.37, Iss.12, 2003-12, pp. : 677-680

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Potentially Significant Drug Interactions of Class III Antiarrhythmic Drugs

By Yamreudeewong W.  

Drug Safety, Vol. 26, Iss. 6, 2003-01 ,pp. : 421-438

Adis International

Access to resources Recommend Favorite

Dofetilide: a class III anti-arrhythmic drug for the treatment of atrial fibrillation

By Torp-Pedersen C.   Brendorp B.   Køber L.  

Expert Opinion on Investigational Drugs, Vol. 9, Iss. 11, 2000-11 ,pp. : 2695-2704

Informa Healthcare

Access to resources Recommend Favorite

Analysis and standardization of the new domestic antiarrhythmic drug bradizol

By Barteneva E.   Stepanenko O.   Avdyunina N.   Bol’shakova R.   Klimova N.   Ustinova M.   Pyatin B.  

Pharmaceutical Chemistry Journal, Vol. 38, Iss. 12, 2004-12 ,pp. : 703-706

Springer Publishing Company

Access to resources Recommend Favorite

Azimilide dihydrochloride: a new class III anti-arrhythmic agent

By Abrol R.   Page R.L.  

Expert Opinion on Investigational Drugs, Vol. 9, Iss. 11, 2000-11 ,pp. : 2705-2715

Informa Healthcare

Access to resources Recommend Favorite

Inhibitory effect of the class III antiarrhythmic drug nifekalant on HERG channels: mode of action

By Kushida S.   Ogura T.   Komuro I.   Nakaya H.  

European Journal of Pharmacology, Vol. 457, Iss. 1, 2002-12 ,pp. : 19-27

Elsevier

Access to resources Recommend Favorite